NCT03598608 · Interventional trial
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin
Delaware Valley sites
- Fox Chase Cancer Center ( Site 0019) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory